Clinical Trials Directory

Trials / Completed

CompletedNCT01506622

Comparison Between Propofol and Fentanyl for Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
222 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
18 Months – 72 Months
Healthy volunteers
Not accepted

Summary

The occurrence of emergence agitation (EA) in pediatric patients who have received sevoflurane anesthesia is a common postoperative problem. The prevalence of EA varies between 10% to 80% depending on the scoring system for evaluation and the anesthetic technique used. Many authors reported various strategies such as use of sedative premedication, change of maintenance technique of anesthesia, or pharmacological agents administered at the end of anesthesia to reduce the incidence and severity of EA, and to allow a smooth emergence from sevoflurane anesthesia. Among these strategies, the use of pharmacological agents at the end of anesthesia is not affected by anesthetic duration, and may not prolong recovery duration of anesthesia excessively when these agents are administered as subhypnotic or small dose. The typical agents that can be administered in this way are propofol and fentanyl. Previous studies demonstrated that the use of either propofol or fentanyl at the end of anesthesia could reduce the incidence of EA. The purpose of this study is to compare the preventive effect on EA and the characteristics of anesthesia recovery between propofol and fentanyl administered at the end of sevoflurane anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGAdministration of propofolPropofol 1 mg/kg will be administered to propofol group at the end of anesthesia.
DRUGAdministration of fentanylFentanyl 1 mcg/kg will be administered to fentanyl group at the end of anesthesia.
DRUGAdministration of salineSaline will be administered to control group at the end of anesthesia.

Timeline

Start date
2011-01-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2012-01-10
Last updated
2015-07-16

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01506622. Inclusion in this directory is not an endorsement.